CD127+ innate lymphoid cells are dysregulated in treatment naïve acute myeloid leukemia patients at diagnosis

Haematologica

Volumn 100, Issue 7, 2015, Pages e257-e260

  Trabanelli, Sara ^a   Curti, Antonio ^b   Lecciso, Mariangela ^b   Salomé, Bérengère ^a   Riether, Carsten ^c   Ochsenbein, Adrian ^c,d   Romero, Pedro ^a   Jandus, Camilla ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Acute myeloid leukemia; CD127+ ILCs; Dysregulated; Innate lymphoid cells; Treatment naive

Indexed keywords

ALPHA INTERFERON; BREFELDIN A; CD14 ANTIGEN; CD33 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA; ANTINEOPLASTIC AGENT; CYTARABINE; DAUNORUBICIN; INTERLEUKIN 7 RECEPTOR ALPHA; INTERLEUKIN DERIVATIVE; TUMOR NECROSIS FACTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; CANCER GROWTH; CANCER THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOGENETICS; DATA PROCESSING; FLOW CYTOMETRY; HUMAN; IMMUNE DYSREGULATION; IMMUNOSURVEILLANCE; INNATE IMMUNITY; LETTER; LEUKEMOGENESIS; LEUKOCYTOSIS; LYMPHOCYTE; BIOSYNTHESIS; CASE CONTROL STUDY; CELL LINEAGE; CLASSIFICATION; DRUG EFFECTS; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; CELL LINEAGE; CYTARABINE; DAUNORUBICIN; FEMALE; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; INTERLEUKINS; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTES; MALE; MIDDLE AGED; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84936075585     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2014.119602     Document Type: Letter

References (12)

1. Eisenring M, vom Berg J, Kristiansen G, Saller E, Becher B. IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp 46. Nat Immunol. 2010;11(11):1030-1038.
2. Shields JD, Kourtis IC, Tomei AA, Roberts JM, Swartz MA. Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL 21. Science. 2010;328(5979):749-752.
3. Kirchberger S, Royston DJ, Boulard O, et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med. 2013;210(5):917-931.
4. Ikutani M, Yanagibashi T, Ogasawara M, et al. Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity. J Immunol. 2012;188(2):703-713.
5. Jovanovic IP, Pejnovic NN, Radosavljevic GD, et al. Interleukin- 33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells. Int J Cancer. 2014;134(7):1669-1682.
6. Munneke JM, Björklund AT, Mjösberg JM, et al. Activated innate lymphoid cells are associated with a reduced susceptibility to graft versus host disease. Blood. 2014;124(5):812-821.
7. Spits H, Artis D, Colonna M, et al. Innate lymphoid cells - a proposal for uniform nomenclature. Nat Rev Immunol. 2013;13(2):145-149.
8. Seillet C, Belz GT, Mielke LA. Complexity of cytokine network regulation of innate lymphoid cells in protective immunity. Cytokine. 2014;70(1):1-10.
9. Sonnenberg GF, Mjosberg J, Spits H, Artis D. SnapShot: Innate lymphoid cells. Immunity. 2013;39(3):662-662.e1
10. Killig M, Glatzer T, Romagnani C. Recognition strategies of group 3 innate lymphoid cells. Front Immunol. 2014;5(142):1-8.
11. Stringaris K, Sekine T, Khoder A, et al. Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia. Haematologica. 2014; 99(5):836-847.
12. Santini V, Gozzini A, Scappini B, Rossi Ferrini P. Maturation and apoptosis of primary human acute myeloblastic leukemia cells are determined by TNF-alpha exclusively through CD120A stimulation. Haematologica. 1999;84(4):291-297.